Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
Holding PRCT?
Track your performance easily
PRCT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$44.02 - $103.81
Previous CloseN/A
Volume113.34K
Average Volume (3M)606.23K
Market Cap
$4.29B
Enterprise Value$4.05B
Total Cash (Recent Filing)$42.02M
Total Debt (Recent Filing)$23.22M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Mar 04, 2025EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.95
Shares Outstanding54,394,722
10 Day Avg. Volume748,777
30 Day Avg. Volume606,230
Standard Deviation0.16
R-Squared0.10
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)20.59
Price to Cash Flow (P/CF)-54.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue20.27
Enterprise Value/Gross Profit57.02
Enterprise Value/Ebitda-42.41
Forecast
1Y Price Target
$103.14Price Target Upside35.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
PROCEPT BioRobotics News
PremiumStock Analysis & Ideas
Morgan Stanley Sees Potential Growth in These 2 Surgical Robotic Stocks
Bulls Say, Bears Say
Bulls Say
Financial PerformancePRCT achieved a 9% revenue beat with 66% year-over-year growth, highlighting its strong performance and potential to continue exceeding investors' expectations.
Market PotentialPRCT's aquablation technology is only approximately 8% penetrated among BPH interventions in the US, suggesting significant growth potential as it expands its reach and adoption.
Product InnovationThe new robot Hydros, with AI automated treatment planning and enhanced visualization, represented 80% of the US systems sold, indicating strong future demand and potential for increased pricing and placements.
Bears Say
Growth PotentialDespite higher ASPs, there are concerns about utilization, which could impact future growth.
Investor SentimentThe main pushback from investors is about valuation, as PRCT is trading at a relatively high multiple to future revenue.
ValuationPRCT trades at a significant premium compared to its high-growth peers, raising concerns about high expectations given the current valuation.
---
Ownership Overview
9.81% Insiders
36.48% Mutual Funds
0.29% Other Institutional Investors
37.65% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PRCT FAQ
What was PROCEPT BioRobotics’s price range in the past 12 months?
PROCEPT BioRobotics lowest stock price was $44.02 and its highest was $103.81 in the past 12 months.
What is PROCEPT BioRobotics’s market cap?
PROCEPT BioRobotics’s market cap is $4.29B.
When is PROCEPT BioRobotics’s upcoming earnings report date?
PROCEPT BioRobotics’s upcoming earnings report date is Mar 04, 2025 which is in 45 days.
How were PROCEPT BioRobotics’s earnings last quarter?
PROCEPT BioRobotics released its earnings results on Oct 28, 2024. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.489 by $0.089.
Is PROCEPT BioRobotics overvalued?
According to Wall Street analysts PROCEPT BioRobotics’s price is currently Undervalued.
Does PROCEPT BioRobotics pay dividends?
PROCEPT BioRobotics does not currently pay dividends.
What is PROCEPT BioRobotics’s EPS estimate?
PROCEPT BioRobotics’s EPS estimate is -0.34.
How many shares outstanding does PROCEPT BioRobotics have?
PROCEPT BioRobotics has 54,394,722 shares outstanding.
What happened to PROCEPT BioRobotics’s price movement after its last earnings report?
PROCEPT BioRobotics reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.489. Following the earnings report the stock price went up 32.325%.
Which hedge fund is a major shareholder of PROCEPT BioRobotics?
Among the largest hedge funds holding PROCEPT BioRobotics’s share is Driehaus Capital Management LLC. It holds PROCEPT BioRobotics’s shares valued at 28M.
---
PROCEPT BioRobotics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$103.14 (35.67% Upside)
$103.14 (35.67% Upside)
Blogger Sentiment
Bullish
PRCT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 102.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $26.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 26.1%
Last 30 Days ▲ 26.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
64.04%
12-Months-Change
Fundamentals
Return on Equity
-37.02%
Trailing 12-Months
Asset Growth
-11.16%
Trailing 12-Months
Company Description
PROCEPT BioRobotics
PROCEPT BioRobotics Corp is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology.
---
PRCT Company Deck
---
PRCT Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, a successful new product launch, and high gross margins, indicating strong business momentum. However, operational challenges due to sales team training and macroeconomic factors like saline shortages and weather events have posed some challenges. The sentiment is positive, with a focus on continued growth and expansion opportunities.Read More>---
PRCT Stock 12 Month Forecast
Average Price Target
$103.14
▲(35.67% Upside)
Technical Analysis
Best Analysts Covering PRCT
1 Year
1 Year Success Rate
17/19 ratings generated profit
1 Year Average Return
+59.45%
assigned a buy rating 3 months ago
Copying Richard Newitter's trades and holding each position for 1 Year would result in 89.47% of your transactions generating a profit, with an average return of +59.45% per trade.
---